New CSO key to driving disruptive technologies development
Dr Daniel Turner has been appointed as Chief Scientific Officer by Enhanc3D Genomics, developers of disruptive technologies aimed at unlocking the 3D spatial genome for target and biomarker discovery. Click to read more...
United Kingdom Wellcome Sanger Hazel Jones Daniel Turner Dan Turner University Of Manchester Institute Science
Source: labmate-online.com